Market Cap: $1.94B Marqeta, Inc. has recently become profitable, reporting a net income of US$54.41 million for the first nine months of 2024, compared to a significant loss in the previous year.
Overview: AbCellera Biologics Inc. operates as a company focused on antibody drug discovery and development, with a market cap of approximately $841.79 million. Operations: The company's revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results